Quantcast
Last updated on May 29, 2012 at 6:23 EDT

Amerigroup Reports Third Quarter 2010 Results; Net Income of $84.3 Million or $1.68 per Diluted Share

October 29, 2010
Repost This

VIRGINIA BEACH, Va., Oct. 29, 2010 /PRNewswire-FirstCall/ — Amerigroup Corporation (NYSE: AGP) today announced that net income for the third quarter of 2010 was $84.3 million, or $1.68 per diluted share, versus net income of $22.5 million, or $0.43 per diluted share, for the third quarter of 2009 and compared to $67.2 million, or $1.31 per diluted share, for the second quarter of 2010.

Highlights include:

  • Membership increased 29,000 members to approximately 1.9 million at the end of the third quarter, a 1.5% increase compared to the second quarter of 2010 and an 8.7% increase over the third quarter of 2009.
  • Third quarter total revenues were $1.5 billion, a 4.0% increase over the second quarter of 2010, and a 14.6% increase over the third quarter of 2009.
  • Health benefits expense was 80.5% of premium revenue for the third quarter of 2010.
  • Selling, general and administrative expenses were 7.1% of total revenues for the third quarter of 2010.
  • Cash flow provided by operations was $92.9 million for the three months ended September 30, 2010.
  • Unregulated cash and investments were $251.4 million as of September 30, 2010.
  • Medical claims payable, as of September 30, 2010, totaled $521.8 million compared to $525.6 million, as of June 30, 2010.
  • Days in claims payable was 40, compared to 41 days in the previous quarter.
  • The Company repurchased approximately 1.9 million shares of its common stock during the third quarter for approximately $70.5 million.

“We are pleased with our performance in the quarter. Our membership grew and we generated strong cash flow, allowing us to build our unregulated cash position, even as we were actively repurchasing shares,” said James G. Carlson, Amerigroup’s chairman and chief executive officer. “Most importantly, we improved the services provided to our members and state partners, continuing our progress to improve access to care and enhance clinical quality outcomes. Our value proposition is being delivered day by day, member by member, at this critical time and our states are saving money and getting better results from their safety net programs.”

Premium Revenue

Premium revenue for the third quarter of 2010 increased 14.7% to $1.5 billion compared to $1.3 billion in the third quarter of 2009. Sequentially, premium revenues increased $61.0 million, or 4.3%, compared with the second quarter of 2010. The sequential increase primarily reflects continued membership increases across many of the Company’s markets.

Third quarter premium revenue also benefited from annual rate increases in several markets including New Jersey, Texas, Virginia and New York, the latter of which was retroactive to April 1, 2010 and recognized in the third quarter.

The Company received initial confirmation of its rate increase in Georgia but did not receive a fully executed rate amendment by the end of the quarter. The Company expects to recognize approximately $0.10 earnings per diluted share in the fourth quarter of 2010 for the retroactive portion of the rate increase associated with the third quarter.

Investment Income and Other Revenues

Third quarter investment income and other revenues were $5.0 million versus $5.3 million in the third quarter of 2009, and compared to $8.6 million in the second quarter of 2010. Investment income and other revenues for the second quarter of 2010 included the sale of a trademark for $4.0 million. Excluding the trademark sale, the slight increase in investment income on a sequential basis is due to a higher average investment yield as well as higher investment balances.

Health Benefits

Health benefits expense, as a percent of premium revenue, was 80.5% for the third quarter of 2010 versus 87.5% in the third quarter of 2009, and compared to 82.3% in the second quarter of 2010.

The sequential decrease in the health benefits ratio was primarily due to the impact of rate increases received in the quarter. Medical cost trends also remained at moderate levels during the third quarter of 2010, consistent with Company experience in the second quarter. Third quarter costs remained in line with, or better than, expectations in most markets, with all major categories of service exhibiting lower trends in recent periods.

Favorable reserve development (net of associated accruals for experience rebate in Texas, applicable medical loss ratio floors, and other gain sharing arrangements with state customers) positively impacted the health benefits ratio in the third quarter by approximately 180 basis points compared to 200 basis points reported in the second quarter of 2010.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were 7.1% of total revenues for the third quarter of 2010, versus 6.3% in the third quarter of 2009, and compared to 7.5% for the second quarter of 2010. Sequentially, selling, general and administrative expenses remained stable, while the selling, general and administrative expense ratio declined due to total revenue growth in the quarter.

Premium Taxes

Third quarter premium taxes were $40.3 million versus $38.3 million for the third quarter of 2009, and compared to $33.2 million in the second quarter of 2010. The sequential increase in premium taxes was primarily due to the reinstatement of premium tax in Georgia effective July 1, 2010.

Balance Sheet Highlights

Cash and investments at September 30, 2010 totaled $1.6 billion of which $251.4 million was unregulated, compared to $239.5 million of unregulated cash and investments at the end of the second quarter of 2010. During the quarter, the Company repurchased 1.9 million shares of common stock for $70.5 million, pursuant to its ongoing share repurchase program. This unregulated cash outlay was offset by dividends and the timing of disbursements during the quarter.

The debt to total capital ratio decreased to 18.2% as of September 30, 2010 from 18.4% as of June 30, 2010.

Medical claims payable as of September 30, 2010 totaled $521.8 million compared to $525.6 million as of June 30, 2010. Days in claims payable represented 40 days of health benefits expense, compared to 41 days in the previous quarter.

Included on page 9 is a table presenting the components of the change in medical claims payable for the nine months ended September 30, 2010 and the year ended December 31, 2009.

Cash Flow Highlights

Cash flow from operations totaled $202.5 million for the nine months ended September 30, 2010 and $92.9 million for the three months ended September 30, 2010. The key driver of cash flow in the quarter was solid earnings with routine variation in working capital accounts.

Third Quarter Earnings Call

Amerigroup senior management will discuss the Company’s third quarter results on a conference call Friday, October 29, 2010 at 8:00 a.m. Eastern Daylight Time (EDT). The conference can be accessed by dialing 866-260-3161 (domestic) or 706-679-7245 (international) approximately ten minutes prior to the start time of the call. A recording of the call may be accessed by dialing 800-642-1687 (domestic) or 706-645-9291 (international) and providing passcode 98624159. The replay will be available shortly after the conclusion of the call until Friday, November 5, at 11:59 p.m. EDT. The conference call will also be available through the investors’ page of the Company’s web site, www.amerigroupcorp.com, or through www.earnings.com. A 30-day replay of this webcast will be available on these web sites beginning approximately two hours following the conclusion of the live broadcast earnings conference call.

About Amerigroup Corporation

Amerigroup, a Fortune 500 Company, coordinates services for individuals in publicly funded health care programs. Serving approximately 1.9 million members in 11 states nationwide, Amerigroup accepts all eligible people regardless of age, sex, race or disability. The Company’s product offerings do not utilize any individual underwriting nor deny coverage due to pre-existing medical conditions. Amerigroup is dedicated to offering real solutions that improve health care access and quality for its members, while proactively working to reduce the overall cost of care to taxpayers. For more information and real story examples of these solutions, please visit www.amerigroupcorp.com.

Forward-Looking Statements

This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the Securities and Exchange Commission’s Fair Disclosure Regulation. This release contains certain ”forward-looking” statements, including statements related to moderating medical cost trends and expected rate increases in the state of Georgia. These statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. These risks and uncertainties include, but are not limited to: our inability to manage medical costs; our inability to operate new products and markets at expected levels, including, but not limited to, profitability, membership and targeted service standards; local, state and national economic conditions, including their effect on the rate-setting process and timing of payments; the effect of government regulations and changes in regulations governing the health care industry, including the impact of recently enacted health care reform legislation; changes in Medicaid and Medicare payment levels and methodologies; increased use of services, increased cost of individual services, epidemics, pandemics, the introduction of new or costly treatments and technology, new mandated benefits, insured population characteristics and seasonal changes in the level of health care use; our ability to maintain and increase membership levels; our ability to enter into new markets or remain in existing markets; changes in market interest rates or any disruptions in the credit markets; our ability to maintain compliance with all minimum capital requirements; liabilities and other claims asserted against us; demographic changes; the competitive environment in which we operate; the availability and terms of capital to fund acquisitions, capital improvements and maintain capitalization levels required by state agencies; our ability to attract and retain qualified personnel; the unfavorable resolution of new or pending litigation; and catastrophes, including acts of terrorism or severe weather.

Investors should also refer to our annual report on Form 10-K for the year ended December 31, 2009 filed with the Securities and Exchange Commission (“SEC”) and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause our actual results to differ materially from our current estimates. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. We specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

               AMERIGROUP CORPORATION AND SUBSIDIARIES
              CONDENSED CONSOLIDATED INCOME STATEMENTS
            (dollars in thousands, except per share data)
                             (unaudited)
                                Three months ended
                                  September 30,
                                  -------------
                                 2010             2009
                                 ----             ----

    Revenues:
        Premium            $1,489,884       $1,298,969
        Investment
         income and
         other                  5,020            5,315
                                -----            -----
           Total revenues   1,494,904        1,304,284
                            ---------        ---------
    Expenses:
        Health benefits     1,199,706        1,136,391
        Selling,
         general and
         administrative       106,815           82,238
        Premium taxes          40,317           38,336
        Depreciation
         and
         amortization           8,737            8,441
        Interest                3,991            3,929
                                -----            -----
           Total expenses   1,359,566        1,269,335
                            ---------        ---------
           Income before
            income taxes      135,338           34,949
    Income tax
     expense                   50,990           12,400
                               ------           ------
           Net income         $84,348          $22,549
                              =======          =======

        Diluted net
         income per
         share                  $1.68            $0.43
                                =====            =====

        Weighted
         average number
         of common
         shares and
          dilutive
          potential
          common
         shares
          outstanding      50,197,740       51,920,745
                           ==========       ==========


                               Nine months ended
                                 September 30,
                                 -------------
                                  2010             2009
                                  ----             ----

    Revenues:
        Premium             $4,285,530       $3,801,306
        Investment
         income and
         other                  18,536           24,179
                                ------           ------
           Total revenues    4,304,066        3,825,485
                             ---------        ---------
    Expenses:
        Health benefits      3,517,723        3,258,907
        Selling,
         general and
         administrative        332,427          288,898
        Premium taxes          104,961          101,077
        Depreciation
         and
         amortization           26,352           26,447
        Interest                12,000           12,399
                                ------           ------
           Total expenses    3,993,463        3,687,728
                             ---------        ---------
           Income before
            income taxes       310,603          137,757
    Income tax
     expense                   116,860           28,700
                               -------           ------
           Net income         $193,743         $109,057
                              ========         ========

        Diluted net
         income per
         share                   $3.81            $2.07
                                 =====            =====

        Weighted
         average number
         of common
         shares and
          dilutive
          potential
          common
         shares
          outstanding       50,895,807       52,754,511
                            ==========       ==========

    The following table sets forth selected operating ratios.  All
    ratios, with the exception of the health benefits ratio,
    are shown as a percentage of total revenues.
                         Three months ended          Nine months ended
                            September 30,              September 30,
                            -------------              -------------
                          2010             2009       2010              2009
                          ----             ----       ----              ----
    Premium
     revenue         99.7%            99.6%      99.6%             99.4%
    Investment
     income and
     other            0.3              0.4        0.4               0.6
                      ---              ---        ---               ---
    Total
     revenues       100.0%           100.0%     100.0%            100.0%
                    =====            =====      =====             =====
    Health
     benefits
     [1]             80.5%            87.5%      82.1%             85.7%
    Selling,
     general and
     administrative
     expenses         7.1%             6.3%       7.7%              7.6%
    Income
     before
     income
     taxes            9.1%             2.7%       7.2%              3.6%
    Net income        5.6%             1.7%       4.5%              2.9%
    [1] The health benefits ratio is shown as a percentage of premium
    revenue because there is a direct relationship between the premium
    received and the health benefits provided.

    The following table sets forth the approximate number of members the
    Company served in each state as of September 30, 2010 and 2009.
    Because the Company receives two premiums for members that are both
    in the Medicare Advantage and Medicaid products, these members have
    been counted twice in the states where we offer both plans.
                                September 30,
                                -------------
                               2010           2009
                               ----           ----
        Texas[1]            557,000        498,000
        Georgia             268,000        236,000
        Florida             263,000        270,000
        Tennessee           204,000        192,000
        Maryland            201,000        188,000
        New Jersey          138,000        117,000
        New York            109,000        112,000
        Nevada               76,000         56,000
        Ohio                 58,000         59,000
        Virginia             38,000         30,000
        New Mexico           21,000         20,000
              Total       1,933,000      1,778,000
                          =========      =========
    [1] Membership includes approximately 14,000 members under an ASO
    contract in 2010 and 13,000 in 2009.

    The following table sets forth the approximate number of members in
    each of the Company's products as of September 30, 2010 and 2009.
    Because the Company receives two premiums for members that are in
    both the Medicare Advantage and Medicaid products, these members
    have been counted in each product.
                                          September 30,
                                          -------------
        Product                          2010            2009
        -------                          ----            ----
        TANF (Medicaid)             1,373,000       1,240,000
        CHIP                          274,000         264,000
        ABD (Medicaid)[1]             197,000         202,000
        FamilyCare (Medicaid)          70,000          58,000
        Medicare Advantage             19,000          14,000
            Total                   1,933,000       1,778,000
                                    =========       =========
    [1]Membership includes approximately 14,000 members under an ASO
    contract in 2010 and 13,000 in 2009.

                    AMERIGROUP CORPORATION AND SUBSIDIARIES
                     CONDENSED CONSOLIDATED BALANCE SHEETS
                 (dollars in thousands, except per share data)
                                  (unaudited)
                                                  September          December
                                                      30,               31,
                                                        2010              2009
                                                        ----              ----

                                       Assets
    Current assets:
        Cash and cash equivalents                   $490,575          $505,915
        Short-term investments                       250,474           137,523
        Premium receivables                          144,044           104,867
        Deferred income taxes                         27,624            26,361
        Prepaid expenses, provider and other
         receivables and other                        55,884            47,316
                                                      ------            ------
         Total current assets                        968,601           821,982

    Property, equipment and software, net             95,458           101,002
    Goodwill                                         260,496           249,276
    Long-term investments, including
     investments on deposit for licensure            823,125           813,976
    Other long-term assets                            13,401            13,398
                                                      ------            ------
                                                  $2,161,081        $1,999,634
                                                  ==========        ==========

                      Liabilities and Stockholders' Equity
    Current liabilities:
        Claims payable                              $521,820          $529,036
        Unearned revenue                              38,299            98,298
        Accounts payable                               3,119             4,685
        Accrued expenses and other                   238,160           127,278
                                                     -------           -------
         Total current liabilities                   801,398           759,297

    Long-term debt                                   243,088           235,104
    Other long-term liabilities                       21,837            20,789
                                                      ------            ------
         Total liabilities                         1,066,323         1,015,190
                                                   ---------         ---------

    Stockholders' equity:
        Common stock, $.01 par value                     550               546
        Additional paid-in capital, net of
         treasury stock                              305,702           391,912
        Accumulated other comprehensive income         4,131             1,354
        Retained earnings                            784,375           590,632
                                                     -------           -------
         Total stockholders' equity                1,094,758           984,444
                                                   ---------           -------
                                                  $2,161,081        $1,999,634
                                                  ==========        ==========

         AMERIGROUP CORPORATION AND SUBSIDIARIES
     CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                       (unaudited)
                                                  Nine months ended
                                                    September 30,
                                                    -------------
                                                  2010               2009
                                                  ----               ----
                                               (dollars in thousands)
    Cash flows from
     operating
     activities:
        Net income                            $193,743           $109,057
        Adjustments to
         reconcile net income
         to net cash provided
         by
          operating activities:
           Depreciation and
            amortization                        26,352             26,447
           Loss on disposal of
            property, equipment
            and software                            17                289
           Deferred tax
            (benefit) expense                   (1,222)             2,481
           Compensation expense
            related to share-
            based payments                      14,594             12,034
           Convertible debt non-
            cash interest
            expense                              7,984              7,480
           Gain on sale of
            intangible assets                   (4,000)                 -
           Gain on sale of
            contract rights                          -             (5,810)
           Other                                 6,772               (326)
           Changes in assets and
            liabilities
            (decreasing)
            increasing cash
            flows
              from operations:
             Premium receivables               (39,177)              (863)
             Prepaid expenses,
              provider and other
              receivables and
              other
                current assets                  (8,144)           (26,534)
             Other assets                         (396)            (1,146)
             Claims payable                     (7,216)            14,005
             Unearned revenue                  (59,999)           (16,481)
             Accounts payable,
              accrued expenses and
              other current
              liabilities                       73,732            (10,245)
             Other long-term
              liabilities                         (533)            (3,793)

                  Net cash provided by
                   operating activities        202,507            106,595
                                               -------            -------

    Cash flows from
     investing
     activities:
          Purchase of
           investments, net                   (115,804)          (221,987)
        Purchase of
         investments on
         deposit for
         licensure, net                         (7,586)            (9,901)
        Purchase of property,
         equipment and
         software                              (19,397)           (21,680)
        Proceeds from sale of
         intangible assets                       4,000                  -
        Proceeds from sale of
         contract rights                             -              5,810
        Purchase of contract
         rights and other
         related assets                        (13,420)                 -
                  Net cash used in
                   investing activities       (152,207)          (247,758)
                                              --------           --------

    Cash flows from
     financing
     activities:
          Repayments of
           borrowings under
           credit facility                           -            (44,318)
        Proceeds and tax
         benefits from
         exercise of stock
         options and change
           in bank overdrafts
            and other, net                      48,495              1,227
        Treasury stock
         repurchases                          (114,135)           (62,828)
                                              --------
                  Net cash used in
                   financing activities        (65,640)          (105,919)
                                               -------           --------
    Net decrease in cash
     and cash equivalents                      (15,340)          (247,082)
    Cash and cash
     equivalents at
     beginning of period                       505,915            763,272
    Cash and cash
     equivalents at end
     of period                                $490,575           $516,190
                                              ========           ========

                    AMERIGROUP CORPORATION AND SUBSIDIARIES
               Components of the Change in Medical Claims Payable
                             (dollars in thousands)
                                    Nine months ended   Twelve months ended
                                   September 30, 2010    December 31, 2009
                                   ------------------    -----------------
    Medical claims payable,
     beginning of period                      $529,036             $536,107

    Health benefits expenses
     incurred during period:
        Related to current year              3,615,124            4,492,590
        Related to prior years                 (97,401)             (85,317)
           Total incurred                    3,517,723            4,407,273
                                             ---------            ---------

    Health benefits payments
     during period:
        Related to current year              3,151,419            4,007,789
        Related to prior years                 373,520              406,555
           Total payments                    3,524,939            4,414,344
                                             ---------            ---------

    Medical claims payable, end of
     period                                   $521,820             $529,036
                                              ========             ========
    Health benefits expenses incurred during both periods were reduced
    for amounts related to prior years.  The amounts related to prior
    years include the impact of amounts previously included in the
    liability to establish it at a level sufficient under moderately
    adverse conditions that were not needed and the reduction in health
    benefits expenses due to revisions to prior estimates.


    CONTACTS:
    Investors:  Julie Loftus
     Trudell                       Media: Tara J. Wall
    Senior Vice President,
     Investor Relations            Senior Vice President, Communications
    Amerigroup Corporation         Amerigroup Corporation
    (757) 321-3597                 (757) 518-3671
    Jtrudel@amerigroupcorp.com     Twall01@amerigroupcorp.com

SOURCE Amerigroup Corporation


Source: newswire